0001104659-24-063003.txt : 20240517 0001104659-24-063003.hdr.sgml : 20240517 20240517161244 ACCESSION NUMBER: 0001104659-24-063003 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240503 FILED AS OF DATE: 20240517 DATE AS OF CHANGE: 20240517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pabon Daniel CENTRAL INDEX KEY: 0001801407 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-55450 FILM NUMBER: 24959803 MAIL ADDRESS: STREET 1: 4880 HAVANA STREET, SUITE 201 CITY: DENVER STATE: CO ZIP: 80212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medicine Man Technologies, Inc. CENTRAL INDEX KEY: 0001622879 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 465289499 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 865 N. ALBION ST. STREET 2: SUITE 300 CITY: DENVER STATE: CO ZIP: 80220 BUSINESS PHONE: 303-371-0387 MAIL ADDRESS: STREET 1: 865 N. ALBION ST. STREET 2: SUITE 300 CITY: DENVER STATE: CO ZIP: 80220 4/A 1 tm2414867-2_4aseq1.xml OWNERSHIP DOCUMENT X0508 4/A 2024-05-03 2024-05-07 0 0001622879 Medicine Man Technologies, Inc. SHWZ 0001801407 Pabon Daniel C/O MEDICINE MAN TECHNOLOGIES, INC. 865 N. ALBION ST., STE. 300 DENVER CO 80220 0 1 0 0 See Remarks 0 Common Stock 2024-05-03 4 F 0 5166 0.62 D 10154 D On May 7, 2024, the reporting person filed a Form 4 reporitng the shares issuable to such reporting person pursuant to the vesting of certain performance stock units ("PSU's"). Such Form 4 inadvertantly did not include the shares withheld to cover the tax withholding obligation in respect of vesting of the reporting person's PSUs. As reported in this amendment, 5,166 shares were withheld to cover the tax withholding obligation in respect of vesting of the reporting person's PSUs. This Form 4 is being amended to report the number of PSU shares issued to the reporting person as the number was unknown at the time of original filing. Chief Policy and Regulatory Affairs Officer /s/ Daniel Pabon 2024-05-17